Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Diagnostics
Diagnostic products company files IND for biopsy product
March 24th, 2005
Neoprobe Corporation (NEOP) announced that the U.S. Food and Drug Administration (FDA) has accepted its request to establish a corporate investigational new drug (IND) application for Lymphoseek. With the establishment of the corporate IND, responsibility for the clinical and commercial development of Lymphoseek has been officially transferred from the University of California, San Diego (UCSD) to Neoprobe. Lymphoseek is intended to be used in biopsy procedures for the detection of lymph nodes in a variety of tumor types including breast, melanoma, prostate, gastric and colon cancers. In connection with the transfer of...
Source: Women's Health Weekly (2005-03-24)
|
